{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:42:49Z","timestamp":1791999769492,"version":"4.4.0"},"reference-count":55,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Physiogenex"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM)"},{"name":"Centre National de la Recherche Scientifique (CNRS)"},{"name":"University of Lille"},{"name":"Institut Pasteur de Lille and the React-EU COVID2I"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Obese patients with non-alcoholic steatohepatitis (NASH) are prone to severe forms of COVID-19. There is an urgent need for new treatments that lower the severity of COVID-19 in this vulnerable population. To better replicate the human context, we set up a diet-induced model of obesity associated with dyslipidemia and NASH in the golden hamster (known to be a relevant preclinical model of COVID-19). A 20-week, free-choice diet induces obesity, dyslipidemia, and NASH (liver inflammation and fibrosis) in golden hamsters. Obese NASH hamsters have higher blood and pulmonary levels of inflammatory cytokines. In the early stages of a SARS-CoV-2 infection, the lung viral load and inflammation levels were similar in lean hamsters and obese NASH hamsters. However, obese NASH hamsters showed worse recovery (i.e., less resolution of lung inflammation 10 days post-infection (dpi) and lower body weight recovery on dpi 25). Obese NASH hamsters also exhibited higher levels of pulmonary fibrosis on dpi 25. Unlike lean animals, obese NASH hamsters infected with SARS-CoV-2 presented long-lasting dyslipidemia and systemic inflammation. Relative to lean controls, obese NASH hamsters had lower serum levels of angiotensin-converting enzyme 2 activity and higher serum levels of angiotensin II\u2014a component known to favor inflammation and fibrosis. Even though the SARS-CoV-2 infection resulted in early weight loss and incomplete body weight recovery, obese NASH hamsters showed sustained liver steatosis, inflammation, hepatocyte ballooning, and marked liver fibrosis on dpi 25. We conclude that diet-induced obesity and NASH impair disease recovery in SARS-CoV-2-infected hamsters. This model might be of value for characterizing the pathophysiologic mechanisms of COVID-19 and evaluating the efficacy of treatments for the severe forms of COVID-19 observed in obese patients with NASH.<\/jats:p>","DOI":"10.3390\/v14092067","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:08:09Z","timestamp":1663718889000},"page":"2067","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters"],"prefix":"10.3390","volume":"14","author":[{"given":"Fran\u00e7ois","family":"Briand","sequence":"first","affiliation":[{"name":"Physiogenex SAS, F-31750 Escalquens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6379-4317","authenticated-orcid":false,"given":"Valentin","family":"Sencio","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-244X","authenticated-orcid":false,"given":"Cyril","family":"Robil","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Heumel","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Deruyter","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-0011","authenticated-orcid":false,"given":"Arnaud","family":"Machelart","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3139-1879","authenticated-orcid":false,"given":"Johanna","family":"Barthelemy","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-8709","authenticated-orcid":false,"given":"Gemma","family":"Bogard","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-1091","authenticated-orcid":false,"given":"Eik","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Infanti","sequence":"additional","affiliation":[{"name":"PLETHA, Institut Pasteur de Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[{"name":"Attoquant Diagnostics, A-1010 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1611-8647","authenticated-orcid":false,"given":"Audrey","family":"Chabrat","sequence":"additional","affiliation":[{"name":"Sciempath Labo, F-37270 Lar\u00e7ay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgile","family":"Richard","sequence":"additional","affiliation":[{"name":"Sciempath Labo, F-37270 Lar\u00e7ay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-3615","authenticated-orcid":false,"given":"Vincent","family":"Pr\u00e9vot","sequence":"additional","affiliation":[{"name":"Univ. Lille, INSERM, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S 1172, European Genomic Institute for Diabetes (EGID), F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9976-9930","authenticated-orcid":false,"given":"Ruben","family":"Nogueiras","sequence":"additional","affiliation":[{"name":"Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), S-15781 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Wolowczuk","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-1487","authenticated-orcid":false,"given":"Florence","family":"Pinet","sequence":"additional","affiliation":[{"name":"Univ. Lille, INSERM, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE-Facteurs de Risque et D\u00e9terminants Mol\u00e9culaires des Maladies Li\u00e9es au Vieillissement, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Sulpice","sequence":"additional","affiliation":[{"name":"Physiogenex SAS, F-31750 Escalquens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3373-1814","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Trottein","sequence":"additional","affiliation":[{"name":"Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/22221751.2021.1898291","article-title":"Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic","volume":"10","author":"To","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"L301","DOI":"10.1152\/ajplung.00259.2020","article-title":"Angiotensin-converting enzyme 2 and COVID-19: Patients, comorbidities, and therapies","volume":"320","author":"Pathangey","year":"2021","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41366-021-00776-8","article-title":"Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: A review and meta-analysis","volume":"45","author":"Aghili","year":"2021","journal-title":"Int. J. Obes."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e13338","DOI":"10.1111\/eci.13338","article-title":"COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics","volume":"50","author":"Portincasa","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_5","first-page":"s176","article-title":"Obesity: Definition, comorbidities, causes, and burden","volume":"22","author":"Apovian","year":"2016","journal-title":"Am. J. Manag. Care."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MOG.0000000000000175","article-title":"Nonalcoholic fatty liver disease: New treatments","volume":"31","author":"Hardy","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tana, C., Ballestri, S., Ricci, F., Di Vincenzo, A., Ticinesi, A., Gallina, S., Giamberardino, M.A., Cipollone, F., Sutton, R., and Vettor, R. (2019). Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173104"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.cmet.2021.09.009","article-title":"Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2","volume":"33","author":"Reiterer","year":"2021","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/oby.23131","article-title":"COVID-19 Vaccination and Obesity: Optimism and Challenges","volume":"29","author":"Townsend","year":"2021","journal-title":"Obesity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1096\/fj.202000782","article-title":"Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?","volume":"34","author":"Yan","year":"2020","journal-title":"FASEB J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/acs.molpharmaceut.0c00608","article-title":"COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies","volume":"18","author":"Salian","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1111\/bph.15143","article-title":"Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology","volume":"177","author":"Cleary","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","article-title":"Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection","volume":"9","author":"Rathnasinghe","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41421-021-00305-x","article-title":"Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Vaisse","year":"1998","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.gene.2017.10.024","article-title":"The evolution of apolipoprotein B and its mRNA editing complex. Does the lack of editing contribute to hypertriglyceridemia?","volume":"641","author":"Damsteegt","year":"2018","journal-title":"Gene"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1248\/bpb.24.579","article-title":"The relationship between plasma high density lipoprotein cholesterol levels and cholesteryl ester transfer protein activity in six species of healthy experimental animals","volume":"24","author":"Tsutsumi","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1194\/jlr.M071183","article-title":"Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans","volume":"57","author":"Takahashi","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.bbadis.2018.04.024","article-title":"Animal models of NAFLD from the pathologist\u2019s point of view","volume":"1865","author":"Denk","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa644","article-title":"Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2018900","DOI":"10.1080\/19490976.2021.2018900","article-title":"Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters","volume":"14","author":"Sencio","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1165\/rcmb.2020-0280LE","article-title":"Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2-infected Hamsters: What Matters?","volume":"63","author":"Gruber","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Port, J.R., Adney, D.R., Schwarz, B., Schulz, J.E., Sturdevant, D.E., Smith, B.J., Avanzato, V.A., Holbrook, M.G., Purushotham, J.N., and Stromberg, K.A. (2021). High-Fat High-Sugar Diet-Induced Changes in the Lipid Metabolism Are Associated with Mildly Increased COVID-19 Severity and Delayed Recovery in the Syrian Hamster. Viruses, 13.","DOI":"10.2139\/ssrn.3894385"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejphar.2017.11.021","article-title":"Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model","volume":"818","author":"Briand","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"154707","DOI":"10.1016\/j.metabol.2021.154707","article-title":"Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters","volume":"117","author":"Briand","year":"2021","journal-title":"Metabolism"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2100200","DOI":"10.1080\/19490976.2022.2100200","article-title":"Alteration of the gut microbiota\u2019s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters","volume":"14","author":"Sencio","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1893113","DOI":"10.1080\/19490976.2021.1893113","article-title":"SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota","volume":"13","author":"Sokol","year":"2021","journal-title":"Gut Microbe"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1073\/pnas.2009799117","article-title":"Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development","volume":"117","author":"Imai","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-0716-0211-9_16","article-title":"Histopathologic Evaluation and Scoring of Viral Lung Infection","volume":"2099","author":"Meyerholz","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1161\/HYPERTENSIONAHA.120.15841","article-title":"Plasma Angiotensin Peptide Profiling and ACE (Angiotensin-Converting Enzyme)-2 Activity in COVID-19 Patients Treated with Pharmacological Blockers of the Renin-Angiotensin System","volume":"76","author":"Kintscher","year":"2020","journal-title":"Hypertension"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/srep05832","article-title":"Association between serum free fatty acid levels and nonalcoholic fatty liver disease: A cross-sectional study","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: The Major Cell Entry Receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/EJE-20-1445","article-title":"Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19","volume":"184","author":"Kutz","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2003730","DOI":"10.1183\/13993003.03730-2020","article-title":"Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: Implications for COVID-19 pathogenesis and consequences","volume":"57","author":"Patel","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Trenell","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.2147\/JIR.S320685","article-title":"Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19","volume":"14","author":"Herr","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"L325","DOI":"10.1152\/ajplung.00189.2020","article-title":"Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury","volume":"319","author":"Sarzani","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12985-021-01604-1","article-title":"Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): A meta-analysis","volume":"18","author":"Liu","year":"2021","journal-title":"Virol. J."},{"key":"ref_43","first-page":"289","article-title":"The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport","volume":"11","author":"Briand","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12944-016-0194-7","article-title":"Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats","volume":"15","author":"Liu","year":"2016","journal-title":"Lipids Health Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jhep.2012.11.014","article-title":"Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins","volume":"58","author":"Walenbergh","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.ATV.20.6.1536","article-title":"Infection and inflammation induce LDL oxidation in vivo","volume":"20","author":"Memon","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"720283","DOI":"10.3389\/fphar.2021.720283","article-title":"The Role of High-Density Lipoprotein in COVID-19","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3389\/fphar.2020.00432","article-title":"Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.14730","article-title":"Pathophysiological mechanisms of liver injury in COVID-19","volume":"41","author":"Nardo","year":"2021","journal-title":"Liver Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and liver disease: Mechanistic and clinical perspectives","volume":"18","author":"Marjot","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"155236","DOI":"10.1016\/j.metabol.2022.155236","article-title":"SARS-CoV-2 infection impairs the insulin\/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1","volume":"133","author":"Shin","year":"2022","journal-title":"Metabolism"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Frere, J.J., Serafini, R.A., Pryce, K.D., Zazhytska, M., Oishi, K., Golynker, I., Panis, M., Zimering, J., Horiuchi, S., and Hoagland, D.A. (2022). SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci. Transl. Med., eabq3059.","DOI":"10.1101\/2022.01.18.476786"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab."},{"key":"ref_55","first-page":"449","article-title":"Insulin resistance in insulin-resistant and diabetic hamsters (Mesocricetus auratus) is associated with abnormal hepatic expression of genes involved in lipid and glucose metabolism","volume":"59","author":"Li","year":"2009","journal-title":"Comp. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/9\/2067\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:33:41Z","timestamp":1760142821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/9\/2067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["v14092067"],"URL":"https:\/\/doi.org\/10.3390\/v14092067","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]}}}